|
|
||||||||
Agonist-Induced Apoptosis of B Lymphocytes and B Lymphoma Cells by an NF-
B-Dependent Mechanism1


* Departments of Environmental Medicine, and Microbiology and Immunology, The Lung Biology and Disease Program, University of Rochester Medical Center, School of Medicine and Dentistry,
Lymphoma Biology Program, James P. Wilmot Cancer Center, Rochester, NY 14642; and
Department of Biochemistry, Hacettepe University, Ankara, Turkey
Peroxisome proliferator-activated receptor
(PPAR
) is a transcription factor important in fat metabolism and is emerging as an important regulator of immunity and inflammation. We previously demonstrated that normal and malignant B lineage cells express PPAR
and die by apoptosis after PPAR
agonist exposure. In this study, we used the WEHI-231 mouse B lymphoma and normal mouse spleen B lymphocytes to elucidate the mechanism of PPAR
agonist-induced apoptosis, and to determine whether an apoptosis rescue mechanism exists. In WEHI-231 cells, the natural PPAR
agonist 15-deoxy-
12,14-PGJ2 and the synthetic PPAR
agonist ciglitazone induced activation of caspase 3 and caspase 9, a decrease in mitochondrial membrane potential, and caused cleavage of the caspase substrate poly(ADP-ribose) polymerase. We next tested whether CD40, whose engagement delivers a potent prosurvival signal for B cells, could protect B cells from PPAR
agonist-induced apoptosis. CD40 engagement with CD40L significantly blunted the ability of PPAR
agonists to induce apoptosis of B lymphocytes and prevented the inhibition of NF-
B mobilization by 15-deoxy-
12,14-PGJ2 and ciglitazone. Interestingly, PPAR
agonists induced an increase in I
B
and I
B
protein levels, which was prevented with CD40 engagement. The rescue mechanism induced by CD40 engagement was dependent on NF-
B, as an NF-
B inhibitor prevented rescue. Apoptosis induction by PPAR
ligands may be important for immune regulation by killing B lymphocytes as a rapid means to dampen inflammation. Moreover, the ability of PPAR
agonists to kill malignant B lineage cells has implications for their use as anti-B lymphoma agents.
This article has been cited by other articles:
![]() |
T. M. Garcia-Bates, C. J. Baglole, M. P. Bernard, T. I. Murant, P. J. Simpson-Haidaris, and R. P. Phipps Peroxisome Proliferator-Activated Receptor {gamma} Ligands Enhance Human B Cell Antibody Production and Differentiation J. Immunol., December 1, 2009; 183(11): 6903 - 6912. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Housley, C. A. O'Conor, F. Nichols, L. Puddington, E. G. Lingenheld, L. Zhu, and R. B. Clark PPAR{gamma} regulates retinoic acid-mediated DC induction of Tregs J. Leukoc. Biol., August 1, 2009; 86(2): 293 - 301. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Bissonnette, J. E. Teague, D. H. Sherr, and J. J. Schlezinger An Endogenous Prostaglandin Enhances Environmental Phthalate-Induced Apoptosis in Bone Marrow B Cells: Activation of Distinct but Overlapping Pathways J. Immunol., August 1, 2008; 181(3): 1728 - 1736. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Milam, V. G. Keshamouni, S. H. Phan, B. Hu, S. R. Gangireddy, C. M. Hogaboam, T. J. Standiford, V. J. Thannickal, and R. C. Reddy PPAR-{gamma} agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis Am J Physiol Lung Cell Mol Physiol, May 1, 2008; 294(5): L891 - L901. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Schlezinger, J. K. Emberley, S. L. Bissonnette, and D. H. Sherr An L-Tyrosine Derivative and PPAR{gamma} Agonist, GW7845, Activates a Multifaceted Caspase Cascade in Bone Marrow B Cells Toxicol. Sci., July 1, 2007; 98(1): 125 - 136. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Wohlfert, F. C. Nichols, E. Nevius, and R. B. Clark Peroxisome Proliferator-Activated Receptor {gamma} (PPAR{gamma}) and Immunoregulation: Enhancement of Regulatory T Cells through PPAR{gamma}-Dependent and -Independent Mechanisms J. Immunol., April 1, 2007; 178(7): 4129 - 4135. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Sui, L. F. Sniderhan, G. Schifitto, R. P. Phipps, H. A. Gelbard, S. Dewhurst, and S. B. Maggirwar Functional Synergy between CD40 Ligand and HIV-1 Tat Contributes to Inflammation: Implications in HIV Type 1 Dementia J. Immunol., March 1, 2007; 178(5): 3226 - 3236. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Brookes, K. Morse, D. Ray, A. Tompkins, S. M. Young, S. Hilchey, S. Salim, M. Konopleva, M. Andreeff, R. Phipps, et al. The Triterpenoid 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic Acid and Its Derivatives Elicit Human Lymphoid Cell Apoptosis through a Novel Pathway Involving the Unregulated Mitochondrial Permeability Transition Pore Cancer Res., February 15, 2007; 67(4): 1793 - 1802. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Ray, F. Akbiyik, and R. P. Phipps The Peroxisome Proliferator-Activated Receptor {gamma} (PPAR{gamma}) Ligands 15-Deoxy-{Delta}12,14-Prostaglandin J2 and Ciglitazone Induce Human B Lymphocyte and B Cell Lymphoma Apoptosis by PPAR{gamma}-Independent Mechanisms J. Immunol., October 15, 2006; 177(8): 5068 - 5076. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-H. Jo, C. Yang, Q. Miao, M. Marzec, M. A. Wasik, P. Lu, and Y. L. Wang Peroxisome Proliferator-Activated Receptor {gamma} Promotes Lymphocyte Survival through Its Actions on Cellular Metabolic Activities J. Immunol., September 15, 2006; 177(6): 3737 - 3745. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Wang, S. Davis, J. R. Cerhan, P. Hartge, R. K. Severson, W. Cozen, Q. Lan, R. Welch, S. J. Chanock, and N. Rothman Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma Carcinogenesis, September 1, 2006; 27(9): 1828 - 1834. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. E. Turner, S. Broad, F. L. Khanim, A. Jeanes, S. Talma, S. Hughes, C. Tselepis, and N. A. Hotchin Slug Regulates Integrin Expression and Cell Proliferation in Human Epidermal Keratinocytes J. Biol. Chem., July 28, 2006; 281(30): 21321 - 21331. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ray, K. Morse, S. Hilchey, T. Garcia, R. Felgar, S. Maggirwar, R. Phipps, and S. H. Bernstein The Novel Triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic Acid (CDDO) Induces Apoptosis of Human Diffuse Large B-Cell Lymphoma Cells (DLCL) through a Peroxisome Proliferator-Activated Receptor {gamma} (PPAR{gamma}) Independent Pathway Which Is Enhanced by NF{kappa}B Inhibition. Blood (ASH Annual Meeting Abstracts), November 16, 2005; 106(11): 2425 - 2425. [Abstract] |
||||
![]() |
S. E. Feldon, D. J. J. Park, C. W. O'Loughlin, V. T. Nguyen, S. Landskroner-Eiger, D. Chang, T. H. Thatcher, and R. P. Phipps Autologous T-Lymphocytes Stimulate Proliferation of Orbital Fibroblasts Derived from Patients with Graves' Ophthalmopathy Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 3913 - 3921. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |